Eli Lilly & Co. (LLY) October weekly option implied volatility bid into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Eli Lilly & Co. (LLY) Misses Q3 EPS by 2c
October 26, 2021 6:26 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.94, $0.02 worse than the analyst estimate of $1.96. Revenue for the quarter came in at $6.77 billion versus the consensus estimate of $6.6 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2021 EPS of $7.95-$8.05, versus the... More
